Team VIVA!
Annual Biotechnology Industry Survey reveals strongest recorded business sentiment across sector since 2011
Almost four-in-five (77 per cent) AusBiotech Industry Survey respondents described the past 12 months as ‘excellent’ or ‘good’ – a five per cent increase on the previous year, and the strongest result recorded since the survey’s inception in 2011. Furthermore, almost 90 per cent of respondents said they expect their business to grow in 2018,…
Read MoreProcedure guidance for medicines funded through Life Saving Drugs Program now available
VIVA! Communications congratulates the Department of Health for its publication of the long-awaited ‘Procedure guidance for medicines funded through the Government’s Life Savings Drugs Program (LSDP) – Version 1.0’. The procedural reform guidance outlines the consideration process for new life saving drugs, and medication reviews, among various other items. VIVA! Communications has a longstanding history…
Read MoreNew challenges for medicinal cannabis
The challenges medicinal cannabis is facing in Australia are coming thick and fast. Well, that’s what the Australian consumer and medical media would have you believe this week with a series of articles questioning the benefits of the plant when it comes to managing chronic pain and reducing opioid use. The coverage has come thanks…
Read MoreNew hires for VIVA! Communications
Leading independent health + wellness communications agency, VIVA! Communications Pty Ltd, is pleased to announce the appointment of Julia Slater as Senior Account Director. Julia is charged with leading a number of multi-national pharmaceutical clientele across VIVA! Communications’ portfolio. Her responsibilities will include growing the agency’s core ethical healthcare practice, building even stronger relationships with…
Read MoreSeqirus joins international vaccine venture to develop long-lasting, universal flu vaccine
Seqirus (owned by CSL) has joined an international, non-profit venture dedicated to decoding the immune system to develop a universal flu vaccine that affords long-lasting protection against seasonal and pandemic influenza across demographics and geography. The Human Vaccines Project aims to decode the human immune system to accelerate development of vaccines and immunotherapies against major…
Read More